Reduced levels of soluble CD14 in atopic children

H A Zdolsek1, M C Jenmalm

  • 1Department of Molecular and Clinical Medicine, Division of Paediatrics, and Clinical Research Centre, Faculty of Health Sciences, Linköping University, Sweden. helzd@imk.liu.se

Insights

Atopic children show reduced soluble CD14 (sCD14) levels, potentially indicating a weaker response to microbial signals. This finding may link reduced microbial exposure to the rise in childhood atopic diseases.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Increasing prevalence of atopic diseases in industrialized nations is linked to reduced microbial stimulation.
  • Antigen-presenting cells (APCs) play a crucial role in Th1/Th2 balance via pattern recognition receptors like CD14.

Purpose of the Study:

  • To investigate if atopic children exhibit lower CD14 expression on monocytes and reduced soluble CD14 (sCD14) levels.
  • To explore the relationship between sCD14 levels and the development of atopic disease in children.

Main Methods:

  • Prospective follow-up of 76 children from birth, evaluating atopic disease signs.
  • Flow cytometry used to analyze monocyte CD14 expression at multiple time points (0-18 months).
  • ELISA for sCD14 and fluoroenzymo immunoassay for total IgE analyzed at various ages, with a subgroup followed to 7 years.

Main Results:

  • Reduced sCD14 levels were observed at 7 years in children with current or cumulative atopy compared to non-atopic children (P=0.002, P=0.001).
  • Children with atopic symptoms and sensitization had significantly lower sCD14 at 3, 18 months, and 7 years compared to non-atopic, non-sensitized children (P=0.023, P=0.039, P=0.008).

Conclusions:

  • Lower sCD14 levels in atopic children might stem from genetic predisposition or the disease itself.
  • These findings suggest that reduced sCD14 could reflect an impaired capacity to respond to microbial signals, contributing to atopy development.
Abstract